M&T Bank’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,368
Closed -$250K 1560
2018
Q2
$250K Sell
4,368
-6,290
-59% -$332K ﹤0.01% 1312
2018
Q1
$491K Buy
10,658
+429
+4% +$20.4K ﹤0.01% 1005
2017
Q4
$472K Sell
10,229
-62
-0.6% -$2.85K ﹤0.01% 1028
2017
Q3
$464K Hold
10,291
﹤0.01% 1025
2017
Q2
$404K Buy
+10,291
New +$389K ﹤0.01% 1066
2016
Q2
Sell
-7,299
Closed -$210K 1699
2016
Q1
$210K Sell
7,299
-1,760
-19% -$46.9K ﹤0.01% 1455
2015
Q4
$303K Sell
9,059
-2,932
-24% -$91.2K ﹤0.01% 1297
2015
Q3
$341K Sell
11,991
-25,175
-68% -$878K ﹤0.01% 1254
2015
Q2
$1.5M Sell
37,166
-1,552
-4% -$69.7K 0.01% 721
2015
Q1
$1.9M Buy
+38,718
New +$1.79M 0.01% 639

Other funds holding AVNS

M&T Bank's AVNS Position: Q3 2018 in Review

M&T Bank sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 4,368 shares — an estimated $250K sold.

M&T Bank first reported a position in AVNS in Q1 2015 and held it in 10 quarters. The position peaked at $1.9M in Q1 2015. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

  • M&T Bank reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
  • M&T Bank sold 4,368 Avanos Medical shares in Q3 2018, an estimated $250K.
  • M&T Bank first reported a position in Avanos Medical in Q1 2015 and held it in 10 quarters.
  • M&T Bank's Avanos Medical position peaked at $1.9M in Q1 2015.
  • 387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on M&T Bank's 13F filing for Q3 2018, filed 9 Nov 2018.